Figure 5
From: The role of HER2 and HER3 in HER2-amplified cancers beyond breast cancers
The compensatory dynamics of HER3 signaling in HER2-amplified cancer cells. The indicated cell lines were treated with 200Â nM lapatinib for the indicated time course and cell signaling studied by western blotting as shown. The majority of these blots reflect single experiments.
